These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29541276)

  • 1. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma.
    Petruzziello A
    Open Virol J; 2018; 12():26-32. PubMed ID: 29541276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.
    Zidan A; Scheuerlein H; Schüle S; Settmacher U; Rauchfuss F
    Hepat Mon; 2012 Oct; 12(10 HCC):e6894. PubMed ID: 23233864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for hepatocellular carcinoma in India.
    Kar P
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.
    Alavian SM; Haghbin H
    Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral hepatitis and hepatocellular carcinoma.
    Michielsen PP; Francque SM; van Dongen JL
    World J Surg Oncol; 2005 May; 3():27. PubMed ID: 15907199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma.
    Stroffolini T; Stroffolini G
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: an update.
    Dominguez-Malagón H; Gaytan-Graham S
    Ultrastruct Pathol; 2001; 25(6):497-516. PubMed ID: 11783914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population.
    Rahat B; Kiran M; Saxena R; Chawla YK; Sharma RR; Kaur J
    J Clin Exp Hepatol; 2012 Jun; 2(2):104-11. PubMed ID: 25755418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and prevention of hepatocellular carcinoma.
    Monto A; Wright TL
    Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
    Lu SN; Su WW; Yang SS; Chang TT; Cheng KS; Wu JC; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Chen CH
    Int J Cancer; 2006 Oct; 119(8):1946-52. PubMed ID: 16708389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in Asia: Prevention strategy and planning.
    Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR
    World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.